HomeMarketsDiscoverWatchlistPortfoliosScreener
Sign Up or Login
  • Belgium

Belgian Pharma Stock News

ENXTBR:MITRA
ENXTBR:MITRAPharmaceuticals

Mithra Pharmaceuticals SA (EBR:MITRA): When Will It Breakeven?

September 27, 2023
With the business potentially at an important milestone, we thought we'd take a closer look at Mithra Pharmaceuticals...
ENXTBR:UCB
ENXTBR:UCBPharmaceuticals

Public companies account for 37% of UCB SA's (EBR:UCB) ownership, while institutions account for 35%

September 03, 2023
Key Insights The considerable ownership by public companies in UCB indicates that they collectively have a greater say...
ENXTBR:UCB
ENXTBR:UCBPharmaceuticals

Is UCB (EBR:UCB) Using Too Much Debt?

August 07, 2023
Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
ENXTBR:MITRA
ENXTBR:MITRAPharmaceuticals

Mithra Pharmaceuticals SA's (EBR:MITRA) market cap dropped €19m last week; Individual investors bore the brunt

August 01, 2023
Key Insights The considerable ownership by individual investors in Mithra Pharmaceuticals indicates that they...
ENXTBR:UCB
ENXTBR:UCBPharmaceuticals

The past three years for UCB (EBR:UCB) investors has not been profitable

July 17, 2023
Many investors define successful investing as beating the market average over the long term. But in any portfolio...
ENXTBR:UCB
ENXTBR:UCBPharmaceuticals

UCB SA's (EBR:UCB) Has Performed Well But Fundamentals Look Varied: Is There A Clear Direction For The Stock?

June 20, 2023
UCB's (EBR:UCB) stock up by 6.6% over the past three months. However, the company's financials look a bit inconsistent...
ENXTBR:UCB
ENXTBR:UCBPharmaceuticals

Are Investors Undervaluing UCB SA (EBR:UCB) By 48%?

June 02, 2023
Key Insights The projected fair value for UCB is €155 based on 2 Stage Free Cash Flow to Equity UCB is estimated to be...
ENXTBR:MITRA
ENXTBR:MITRAPharmaceuticals

Take Care Before Diving Into The Deep End On Mithra Pharmaceuticals SA (EBR:MITRA)

May 23, 2023
You may think that with a price-to-sales (or "P/S") ratio of 2.2x Mithra Pharmaceuticals SA ( EBR:MITRA ) is a stock...
ENXTBR:UCB
ENXTBR:UCBPharmaceuticals

Just Four Days Till UCB SA (EBR:UCB) Will Be Trading Ex-Dividend

April 23, 2023
It looks like UCB SA ( EBR:UCB ) is about to go ex-dividend in the next 4 days. The ex-dividend date is usually set to...
ENXTBR:UCB
ENXTBR:UCBPharmaceuticals

UCB's (EBR:UCB) Upcoming Dividend Will Be Larger Than Last Year's

April 05, 2023
The board of UCB SA ( EBR:UCB ) has announced that it will be paying its dividend of €0.931 on the 3rd of May, an...
ENXTBR:HYL
ENXTBR:HYLPharmaceuticals

Hyloris Pharmaceuticals Reports Full Year 2022 Earnings

March 17, 2023
Hyloris Pharmaceuticals ( EBR:HYL ) Full Year 2022 Results Key Financial Results Net loss: €10.8m (loss narrowed by...
ENXTBR:MITRA
ENXTBR:MITRAPharmaceuticals

Mithra Pharmaceuticals Reports Full Year 2022 Earnings

March 10, 2023
Mithra Pharmaceuticals ( EBR:MITRA ) Full Year 2022 Results Key Financial Results Revenue: €67.0m (up 196% from FY...
ENXTBR:UCB
ENXTBR:UCBPharmaceuticals

UCB Full Year 2022 Earnings: Revenues Beat Expectations, EPS Lags

February 26, 2023
UCB ( EBR:UCB ) Full Year 2022 Results Key Financial Results Revenue: €5.45b (down 5.7% from FY 2021). Net income...
ENXTBR:MITRA
ENXTBR:MITRAPharmaceuticals

Shareholders in Mithra Pharmaceuticals (EBR:MITRA) have lost 90%, as stock drops 12% this past week

February 11, 2023
As an investor, mistakes are inevitable. But really big losses can really drag down an overall portfolio. So take a...
ENXTBR:HYL
ENXTBR:HYLPharmaceuticals

Hyloris Pharmaceuticals SA's (EBR:HYL) Profit Outlook

January 17, 2023
Hyloris Pharmaceuticals SA ( EBR:HYL ) is possibly approaching a major achievement in its business, so we would like to...
  • 1

Make Confident Investment Decisions

Simply Wall St's Editorial Team provides unbiased, factual reporting on global stocks using in-depth fundamental analysis.
Find out more about our editorial guidelines and team.

Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
  • About
  • Careers
  • Plans
  • Log In
  • Help Centre
  • Latest Coverage
  • Podcasts
  • Financial Services Guide
  • Terms and Conditions
  • Privacy Policy

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.